Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Morton

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Pediatric Blood & Cancer|October 27, 2009
Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing programMalcolm A Smith, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|August 27, 2010
Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing programHernan Carol, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing of lenalidomide by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, Stephen T Keir, et al.
Journal of Medicinal Chemistry|April 15, 2005
Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterasesRandy M Wadkins, Janice L Hyatt, Xin Wei, et al.
Pediatric Blood & Cancer|February 22, 2011
Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing programPeter J Houghton, Richard Gorlick, E Anders Kolb, et al.
Pediatric Blood & Cancer|May 18, 2011
Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing programRichard B Lock, Hernan Carol, Christopher L Morton, et al.
Pediatric Blood & Cancer|May 4, 2011
Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, Peter J Houghton, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Pediatric Blood & Cancer|January 22, 2013
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing programStephen T Keir, John M Maris, C Patrick Reynolds, et al.
Pediatric Blood & Cancer|February 9, 2012
Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|October 27, 2009
Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing programMalcolm A Smith, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|August 27, 2010
Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing programHernan Carol, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing of lenalidomide by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, Stephen T Keir, et al.
Journal of Medicinal Chemistry|April 15, 2005
Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterasesRandy M Wadkins, Janice L Hyatt, Xin Wei, et al.
Pediatric Blood & Cancer|February 22, 2011
Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing programPeter J Houghton, Richard Gorlick, E Anders Kolb, et al.
Pediatric Blood & Cancer|May 18, 2011
Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing programRichard B Lock, Hernan Carol, Christopher L Morton, et al.
Pediatric Blood & Cancer|May 4, 2011
Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, Peter J Houghton, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Pediatric Blood & Cancer|January 22, 2013
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing programStephen T Keir, John M Maris, C Patrick Reynolds, et al.
Pediatric Blood & Cancer|February 9, 2012
Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Pageof 10